APOB and hepatocellular carcinoma: Taken together, the potential regulatory pathways in HCC patients were identified as the CYTOR/hsa-miR-877-5p/APOB; CRNDE/hsa-miR-9-5p/APOB; MUC20-OT1/hsa-miR-877-5p/APOB; LINC00511/hsa-miR-9-5p/APOB; LINC01089/hsa-miR-877-5p/APOB; MALAT1/hsa-miR-21-5p/APOB axis.